Search Results - "Mulford, J"

Refine Results
  1. 1
  2. 2
  3. 3

    A Population Pharmacokinetic Model of Vonoprazan: Evaluating the Effects of Race, Disease Status, and Other Covariates on Exposure by Scarpignato, Carmelo, Leifke, Eckhard, Smith, Neila, Mulford, Darcy J., Lahu, Gezim, Facius, Axel, Howden, Colin W.

    Published in Journal of clinical pharmacology (01-06-2022)
    “…Vonoprazan, a potassium‐competitive acid blocker, is under investigation in the United States and Europe for the treatment of erosive esophagitis and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Proximal Row Carpectomy vs Four Corner Fusion for Scapholunate (Slac) or Scaphoid Nonunion Advanced Collapse (Snac) Wrists: A Systematic Review of Outcomes by MULFORD, J. S., CEULEMANS, L. J., NAM, D., AXELROD, T. S.

    Published in Journal of Hand Surgery (01-04-2009)
    “…Proximal row carpectomy (PRC) and scaphoid excision with four-corner fusion (4CF) are common motion-preserving, salvage procedures for the treatment of wrists…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Metabolism and Excretion of [14C] Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase, in Healthy Male Subjects by Grabowski, Brian A., Khosravan, Reza, Vernillet, Laurent, Mulford, Darcy J.

    Published in Journal of clinical pharmacology (01-02-2011)
    “…Absorption, metabolism, and excretion of one 80 mg oral dose of [14C] febuxostat ([thiazole‐4‐14C] 2‐[3‐cyano‐4‐isobutoxyphenyl]‐4‐methyl‐5‐thiazolecarboxylic…”
    Get full text
    Journal Article
  8. 8

    Tiered approach to evaluate the CYP3A victim and perpetrator drug–drug interaction potential for vonoprazan using PBPK modeling and clinical data to inform labeling by Mulford, Darcy J., Ramsden, Diane, Zhang, Liming, Michon, Ingrid, Leifke, Eckhard, Smith, Neila, Jones, Hannah M., Scarpignato, Carmelo

    “…Vonoprazan is metabolized extensively through CYP3A and is an in vitro time‐dependent inhibitor of CYP3A. A tiered approach was applied to understand the CYP3A…”
    Get full text
    Journal Article
  9. 9

    Recreational off-highway vehicle exposure, safety behaviors and crash experiences among adolescents by Jennissen, Charles A, Schaeffer, Sienna E, Hoogerwerf, Pamela J, Wetjen, Kristel M, Mulford, Lauren J, Champoux, Katharine L, Okoro, Uche E, Denning, Gerene M

    Published in Injury epidemiology (21-12-2022)
    “…Recreational off-highway vehicles (ROVs), often called utility task vehicles (UTVs), are designed to be driven by those ≥ 16 years and manufacturers recommend…”
    Get full text
    Journal Article
  10. 10

    All-terrain vehicle exposure and the association of certified training on adolescent safety behaviors and crash experiences by Jennissen, Charles A, Champoux, Katharine L, Hoogerwerf, Pamela J, Wetjen, Kristel M, Mulford, Lauren J, Schaeffer, Sienna E, Okoro, Uche E, Denning, Gerene M

    Published in Injury epidemiology (21-12-2022)
    “…Certified training courses in all-terrain vehicle (ATV) operation are recommended, but little has been published regarding how they affect riding behaviors…”
    Get full text
    Journal Article
  11. 11

    Pharmacodynamics and Pharmacokinetics of the Potassium-Competitive Acid Blocker Vonoprazan and the Proton Pump Inhibitor Lansoprazole in US Subjects by Laine, Loren, Sharma, Prateek, Mulford, Darcy J., Hunt, Barbara, Leifke, Eckhard, Smith, Neila, Howden, Colin W.

    Published in The American journal of gastroenterology (01-07-2022)
    “…We assessed pharmacodynamics and pharmacokinetics of a potassium-competitive acid blocker and proton pump inhibitor in U.S. subjects. Healthy adults were…”
    Get full text
    Journal Article
  12. 12

    S524 Bioequivalence of Vonoprazan Sprinkle Capsule and Vonoprazan Tablet in Healthy Subjects by Chang, Yu-Ming, Leifke, Eckhard, Smith, Neila, Witt, Galen, Mulford, Darcy J.

    Published in The American journal of gastroenterology (01-10-2023)
    “…Methods: In this phase 1, single-dose, open-label, randomized, 3-period, 3-sequence crossover study, the bioavailability of a 20 mg vonoprazan sprinkle…”
    Get full text
    Journal Article
  13. 13

    Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations by Mulford, Ashley J, Wing, Claudia, Dolan, M Eileen, Wheeler, Heather E

    Published in Human molecular genetics (26-04-2021)
    “…Abstract Most cancer chemotherapeutic agents are ineffective in a subset of patients; thus, it is important to consider the role of genetic variation in drug…”
    Get full text
    Journal Article
  14. 14

    A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection by Scarpignato, Carmelo, Howden, Colin W., Leifke, Eckhard, Mulford, Darcy J., Lahu, Gezim, Facius, Axel, Hunt, Richard

    Published in Alimentary pharmacology & therapeutics (01-07-2023)
    “…Summary Background Treatment of acid‐related disorders relies on gastric acid suppression. The percentage of time intragastric pH is >4 (pH >4 holding time…”
    Get full text
    Journal Article
  15. 15

    The Effect of Food on the Pharmacokinetics of the Potassium‐Competitive Acid Blocker Vonoprazan by Mulford, Darcy J., Leifke, Eckhard, Hibberd, Mark, Howden, Colin W.

    Published in Clinical pharmacology in drug development (01-02-2022)
    “…Herein, we report a food‐effect study of vonoprazan, an oral potassium‐competitive acid blocker. In a phase 1, randomized, open‐label, crossover study, healthy…”
    Get full text
    Journal Article
  16. 16

    Response to Graham by Laine, Loren, Sharma, Prateek, Mulford, Darcy J., Hunt, Barbara, Leifke, Eckhard, Smith, Neila, Howden, Colin W.

    Published in The American journal of gastroenterology (01-11-2022)
    “…Dr. Graham requests additional information regarding the protocol of our study comparing the pharmacodynamics of the potassium-competitive blocker, vonoprazan,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A prospective evaluation of trochleoplasty for the treatment of patellofemoral dislocation and instability by UTTING, M. R, MULFORD, J. S, ELDRIDGE, J. D. J

    “…Trochlear dysplasia is a developmental condition characterised by an abnormally flat or dome-shaped trochlea and is an important contributory factor to…”
    Get full text
    Journal Article
  19. 19

    Benjamin Franklin and Women: Or, Franklin's Women by Mulford, Carla J.

    Published in Pennsylvania history (01-07-2020)
    “…Reappraising Benjamin Franklin in the context of the politics of his day, this article examines how his supposed questionable reputation with women dates to…”
    Get full text
    Journal Article
  20. 20

    Comparative pharmacokinetics and safety of lansoprazole oral capsules and orally disintegrating tablets in healthy subjects by Freston, J. W., Chiu, Y.‐L., Mulford, D. J., Ballard II, E. D.

    Published in Alimentary pharmacology & therapeutics (01-02-2003)
    “…Summary Background : Many individuals with acid‐related gastrointestinal disorders have difficulty in swallowing oral agents. Aim : To compare the…”
    Get full text
    Journal Article